Type to search

PEP-Therapy and Institut Curie Announce First Patients Dosed in Phase I Clinical Trial of PEP-010 for the Treatment of Advanced Solid Tumors | Pharmtech Focus
PEP-Therapy Extends Series-A Financing, Raising a Total of €5.4 Million to Progress the Clinical Development of its Lead Candidate PEP-010 | Pharmtech Focus